These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 14719451)

  • 1. [Urethral stent (Memotherm) for the treatment of benign prostatic hyperplasia].
    Noda Y; Ujike T; Oka D; Takada S; Fujimoto N; Koide T
    Hinyokika Kiyo; 2003 Nov; 49(11):645-7. PubMed ID: 14719451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urethral stent (Angiomed-Memotherm) implantation in high-risk patients with urinary retention.
    Uchikoba T; Horiuchi K; Satoh M; Oka F; Saitoh Y; Tsuboi N; Nishimura T
    Hinyokika Kiyo; 2005 Apr; 51(4):235-9. PubMed ID: 15912781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Outcome analysis of the urethral stent (Memotherm®)].
    Sakamoto H; Matsuda A; Arakaki R; Yamada H
    Hinyokika Kiyo; 2012 Jan; 58(1):13-6. PubMed ID: 22343737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of benign prostatic hyperplasia in high risk patients: long-term experience with the Memotherm stent.
    Gesenberg A; Sintermann R
    J Urol; 1998 Jul; 160(1):72-6. PubMed ID: 9628608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study.
    Kotsar A; Isotalo T; Juuti H; Mikkonen J; Leppiniemi J; Hänninen V; Kellomäki M; Talja M; Tammela TL
    BJU Int; 2009 Mar; 103(5):626-9. PubMed ID: 18990149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of urethral stent under metal bougie guidance].
    Isogawa Y; Ohmori K
    Hinyokika Kiyo; 1993 Mar; 39(3):231-5. PubMed ID: 7685141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical efficacy of the Porges Urospiral, a reversible intraprostatic spiral stent, in patients with benign prostatic hypertrophy].
    Uchida J; Kawamura H; Fujita I; Oguchi N; Matsuda T; Ashida M; Kikkawa A; Doi T; Amazutsumi K; Ohara T
    Hinyokika Kiyo; 1995 Apr; 41(4):323-8. PubMed ID: 7540360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with a new intraurethral stent for high-risk patients with benign prostatic hypertrophy.
    Fuse H; Okumura A; Sakamoto M; Katayama T
    Int Urol Nephrol; 1993; 25(4):369-74. PubMed ID: 7506240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term results and indications of intraurethral stents in elderly patients with prostatic hypertrophy complaining of urinary retention].
    Takeda M; Takahashi H; Tsutsui T; Go H; Hatano A; Sato S; Sasagawa T; Sakata Y; Hiraiwa M; Ando T
    Hinyokika Kiyo; 1993 Nov; 39(11):1011-5. PubMed ID: 7505521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experience of a double Malecot polyurethane intraurethral catheter in patients with dysuria].
    Okumura A; Muraishi Y; Tsuritani S; Nagakawa O; Sakamoto M; Kazama T; Fuse H; Katayama T
    Hinyokika Kiyo; 1994 May; 40(5):383-6. PubMed ID: 7517619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of a metallic prostatic stent].
    Yasumoto R; Yoshihara H; Kishimoto T; Maekawa M
    Hinyokika Kiyo; 1991 Nov; 37(11):1467-70. PubMed ID: 1722635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic stents and balloon dilatation.
    McLoughlin J; Williams G
    Br J Hosp Med; 1990 Jun; 43(6):422-6. PubMed ID: 1694704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia.
    Masood S; Djaladat H; Kouriefs C; Keen M; Palmer JH
    BJU Int; 2004 Dec; 94(9):1271-4. PubMed ID: 15610103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of lower urinary tract symptoms secondary to benign prostatic hyperplasia with open prostatectomy: results of a contemporary series.
    Helfand B; Mouli S; Dedhia R; McVary KT
    J Urol; 2006 Dec; 176(6 Pt 1):2557-61; discussion 2561. PubMed ID: 17085158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
    Desgrandchamps F; De La Taille A; Doublet JD;
    BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of UroLume as an alternative to the treatment of recurrent stenosis of bulbar urethra and obstructive prostatic hyperplasia in patients with high surgical risk].
    Serrano-Brambila EA; Camacho-Carvajal JC; Moreno-Aranda J; Martínez-Sánchez R
    Gac Med Mex; 2003; 139(5):435-48. PubMed ID: 14635562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of prostatic stent treatment for benign prostatic hyperplasia.
    Chiou RK; Chen WS; Akbari A; Foley S; Lynch B; Taylor RJ
    Urology; 1996 Oct; 48(4):589-93. PubMed ID: 8886065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mesh-like tubular stent treatment for chronic urinary retention caused by benign prostatic hypertrophy].
    Wang X; Zhu J; Hou S
    Zhonghua Wai Ke Za Zhi; 1996 Feb; 34(2):107-9. PubMed ID: 9388336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Benign hypertrophy of the prostate].
    Descazeaud A; de La Taille A
    Rev Prat; 2006 Dec; 56(20):2283-9. PubMed ID: 17352329
    [No Abstract]   [Full Text] [Related]  

  • 20. Transurethral ethanol injection for prostatic obstruction: an excellent treatment strategy for persistent urinary retention.
    Mutaguchi K; Matsubara A; Kajiwara M; Hanada M; Mizoguchi H; Ohara S; Yasumoto H; Usui T
    Urology; 2006 Aug; 68(2):307-11. PubMed ID: 16904442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.